108 related articles for article (PubMed ID: 30598263)
41. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
42. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells.
Chang GC; Yu CT; Tsai CH; Tsai JR; Chen JC; Wu CC; Wu WJ; Hsu SL
Eur J Pharmacol; 2008 Dec; 600(1-3):37-44. PubMed ID: 18973751
[TBL] [Abstract][Full Text] [Related]
43. Protein phosphatase 2A mediates JS-K-induced apoptosis by affecting Bcl-2 family proteins in human hepatocellular carcinoma HepG2 cells.
Liu L; Huang Z; Chen J; Wang J; Wang S
J Cell Biochem; 2018 Aug; 119(8):6633-6643. PubMed ID: 29693750
[TBL] [Abstract][Full Text] [Related]
44. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
45. Antihepatocellular Carcinoma Potential of Tetramethylpyrazine Induces Cell Cycle Modulation and Mitochondrial-Dependent Apoptosis: Regulation of p53 Signaling Pathway in HepG2 Cells In Vitro.
Bi L; Yan X; Chen W; Gao J; Qian L; Qiu S
Integr Cancer Ther; 2016 Jun; 15(2):226-36. PubMed ID: 27179035
[TBL] [Abstract][Full Text] [Related]
46. Anti-hepatoma activities of ethyl acetate extract from Ampelopsis sinica root.
Wang JZ; Huang BS; Cao Y; Chen KL; Li J
Oncol Rep; 2017 Apr; 37(4):2227-2236. PubMed ID: 28350090
[TBL] [Abstract][Full Text] [Related]
47. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
48. Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.
Sun J; Wang B; Liu Y; Zhang L; Ma A; Yang Z; Ji Y; Liu Y
Cancer Lett; 2014 Dec; 355(1):25-33. PubMed ID: 25242357
[TBL] [Abstract][Full Text] [Related]
49. Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53.
Rogalska A; Sliwinska A; Kasznicki J; Drzewoski J; Marczak A
Asian Pac J Cancer Prev; 2016; 17(3):993-1001. PubMed ID: 27039825
[TBL] [Abstract][Full Text] [Related]
50. Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells.
Jiang MC; Luo SF; Li LT; Lin CC; Du SY; Lin CY; Hsu YW; Liao CF
J Exp Clin Cancer Res; 2007 Mar; 26(1):91-9. PubMed ID: 17550137
[TBL] [Abstract][Full Text] [Related]
51. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
[TBL] [Abstract][Full Text] [Related]
52. Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.
Yi G; He Z; Zhou X; Xian L; Yuan T; Jia X; Hong J; He L; Liu J
Int J Oncol; 2013 Nov; 43(5):1503-10. PubMed ID: 23982736
[TBL] [Abstract][Full Text] [Related]
53. Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway.
Guo XX; Li XP; Zhou P; Li DY; Lyu XT; Chen Y; Lyu YW; Tian K; Yuan DZ; Ran JH; Chen DL; Jiang R; Li J
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30384473
[TBL] [Abstract][Full Text] [Related]
54. HZ-6d targeted HERC5 to regulate p53 ISGylation in human hepatocellular carcinoma.
Wang Y; Ding Q; Xu T; Li CY; Zhou DD; Zhang L
Toxicol Appl Pharmacol; 2017 Nov; 334():180-191. PubMed ID: 28919514
[TBL] [Abstract][Full Text] [Related]
55. Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects.
Carlisi D; Vassallo B; Lauricella M; Emanuele S; D'Anneo A; Di Leonardo E; Di Fazio P; Vento R; Tesoriere G
Int J Oncol; 2008 Jan; 32(1):177-84. PubMed ID: 18097557
[TBL] [Abstract][Full Text] [Related]
56. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
[TBL] [Abstract][Full Text] [Related]
57. Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells.
Xie SB; He XX; Yao SK
Int J Oncol; 2015 Aug; 47(2):517-26. PubMed ID: 26034977
[TBL] [Abstract][Full Text] [Related]
58. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
[TBL] [Abstract][Full Text] [Related]
59. S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells.
Tong D; Qu H; Meng X; Jiang Y; Liu D; Ye S; Chen H; Jin Y; Fu S; Geng J
Oncol Rep; 2014 Sep; 32(3):1124-32. PubMed ID: 24970681
[TBL] [Abstract][Full Text] [Related]
60. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
Lo SJ; Fan LC; Tsai YF; Lin KY; Huang HL; Wang TH; Liu H; Chen TC; Huang SF; Chang CJ; Lin YJ; Yung BY; Hsieh SY
Hepatology; 2013 May; 57(5):1893-905. PubMed ID: 23258611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]